Latest news with #Nootropics
Associated Press
04-08-2025
- Business
- Associated Press
Nootropics Depot's Tongkat Ali Declared Most Cost-Efficient and Potent in Industry, According to Independent Lab Tests
TEMPE, Ariz., Aug. 4, 2025 /PRNewswire/ -- New independent UPLC laboratory testing has confirmed that Nootropics Depot's Tongkat Ali extracts are the industry's leading choice for both cost efficiency and potency, dramatically outpacing seven major competitors. This robust data, generated by advanced Ultra-Performance Liquid Chromatography (UPLC), positions Nootropics Depot as the category benchmark for quality and transparency in the Tongkat Ali supplement market. Key findings highlight: These results are detailed in a transparent, third-party report and set a new standard for evidence-based supplement selection. 'We've always believed the best way to earn customer trust is transparency,' said Paul Eftang, CEO of Nootropics Depot. 'This independent lab data is validation for consumers. Not only are we delivering more of Tongkat Ali's active compounds, we're setting the bar for value, potency, and scientific rigor in an industry notorious for marketing hype.' 'Consumers deserve clear, standardized information so they can make meaningful health decisions — not just clever branding and proprietary blends,' Eftang added. 'We invite every brand to publish their own lab results. This is how the industry should operate.' Nootropics Depot offers three main Tongkat Ali options: Additionally, the company's transparent and published testing methods allow consumers to easily compare products, moving the supplement industry toward higher standards of honesty and efficacy. Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned website features a user-friendly interface, and includes an innovative quiz to help beginners find the right supplements for their needs. With partnerships with third-party labs, and collaboration with the Future Nutra Foundation, Nootropics Depot continues to push the boundaries of supplement quality and consumer education. For more information about Nootropics Depot's products and their commitment to transparency, visit Media Contact Michael Packman Marketing Manager Nootropics Depot [email protected] View original content to download multimedia: SOURCE Nootropics Depot
Yahoo
04-08-2025
- Business
- Yahoo
Nootropics Depot's Tongkat Ali Declared Most Cost-Efficient and Potent in Industry, According to Independent Lab Tests
TEMPE, Ariz., Aug. 4, 2025 /PRNewswire/ -- New independent UPLC laboratory testing has confirmed that Nootropics Depot's Tongkat Ali extracts are the industry's leading choice for both cost efficiency and potency, dramatically outpacing seven major competitors. This robust data, generated by advanced Ultra-Performance Liquid Chromatography (UPLC), positions Nootropics Depot as the category benchmark for quality and transparency in the Tongkat Ali supplement market. Key findings highlight: Nootropics Depot's 10% eurycomanone extract delivers 18.0mg of active eurycomanone per dollar, a 3.3x cost advantage over the nearest competitor and up to 40x more value than premium-priced brands. Its 10% extract provides 10–12mg of lab-verified eurycomanone per 100mg dose, while competitors typically yield only 0.13–4mg per dose. Cost per mg of eurycomanone for Nootropics Depot's 10% extract is just $0.06, compared to $0.20 to $5.77 from competitors, leading to as much as 96x more active compounds per dollar spent. These results are detailed in a transparent, third-party report and set a new standard for evidence-based supplement selection. "We've always believed the best way to earn customer trust is transparency," said Paul Eftang, CEO of Nootropics Depot. "This independent lab data is validation for consumers. Not only are we delivering more of Tongkat Ali's active compounds, we're setting the bar for value, potency, and scientific rigor in an industry notorious for marketing hype." "Consumers deserve clear, standardized information so they can make meaningful health decisions — not just clever branding and proprietary blends," Eftang added. "We invite every brand to publish their own lab results. This is how the industry should operate." Nootropics Depot offers three main Tongkat Ali options: Tongkat Ali 10% Tablets: Highest potency, delivering up to 12mg eurycomanone per 100mg dose. Tongkat Ali 2% Capsules: Full-spectrum, balanced option with 4mg per 200mg dose. Eurycomax Optimized Stack: Combines two extraction methods with synergistic ingredients for broader hormonal support. Additionally, the company's transparent and published testing methods allow consumers to easily compare products, moving the supplement industry toward higher standards of honesty and efficacy. Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned website features a user-friendly interface, and includes an innovative quiz to help beginners find the right supplements for their needs. With partnerships with third-party labs, and collaboration with the Future Nutra Foundation, Nootropics Depot continues to push the boundaries of supplement quality and consumer education. For more information about Nootropics Depot's products and their commitment to transparency, visit Media ContactMichael PackmanMarketing ManagerNootropics Depotmichael@ View original content to download multimedia: SOURCE Nootropics Depot Sign in to access your portfolio
Associated Press
16-07-2025
- Health
- Associated Press
Nootropics Depot Unveils Eurycomax, an Optimized Tongkat Ali Stack
TEMPE, Ariz., July 16, 2025 /PRNewswire/ -- Nootropics Depot, a leading manufacturer of research-backed dietary supplements, announced the launch of Eurycomax, its most advanced Tongkat Ali formulation to date. The dual-extract stack pairs a 10% eurycomanone Tongkat Ali with a cold-water ultrasonic extract and five synergistic ingredients—Horny Goat Weed, Mucuna pruriens, pregnenolone, boron, and iodine—to support healthy testosterone, motivation, and recovery in a single daily serving. Designed for Balanced Testosterone Support Eurycomax delivers 7 mg of eurycomanone per two-capsule serving while preserving a broad spectrum of quassinoids through the novel cold-water extract. 'Our R&D goal was to capture the full breadth of Tongkat Ali's bioactives without sacrificing potency,' said Paul Eftang, CEO of Nootropics Depot. 'Combining targeted standardization with ultrasonic extraction lets us do that in a clinically meaningful dose.' Key bioactives include: Backed by ISO-Accredited Testing All raw materials and finished batches undergo identity, potency, and contaminant screening in Nootropics Depot's ISO/IEC 17025-accredited analytical laboratory. Certificates of analysis are posted on each product page, continuing the company's 'Transparency You Can See' ethos. Addressing Real-World Feedback Formulation decisions were informed by five years of customer blood-work data and anecdotal reports on classic Tongkat Ali side effects such as low estradiol, joint discomfort, and rising prolactin. Eurycomax counterbalances these issues by integrating icariin and L-DOPA at tolerable levels. 'People love Tongkat Ali's drive and strength gains but don't want hormone imbalances in month three,' Eftang noted. 'Eurycomax smooths the curve so users feel motivated, resilient, and consistent in the gym and at work.' Availability Eurycomax is now shipping worldwide through in 60-capsule bottles (30-day supply). 'Quality is everything to us. With Eurycomax we didn't just raise health and vitality—we raised the standard for nutraceutical stacks that respect the whole endocrine picture,' said Eftang. For more on the science and story behind Eurycomax, listen to the full podcast interview with Nootropics Depot's product specialist Emiel Bakker: About Nootropics Depot Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned website features a user-friendly interface, and includes an innovative quiz to help beginners find the right supplements for their needs. With partnerships with third-party labs, and collaboration with the Future Nutra Foundation, Nootropics Depot continues to push the boundaries of supplement quality and consumer education. For more information about Nootropics Depot's products and their commitment to transparency, visit Media Contact Michael Packman Marketing Manager Nootropics Depot [email protected] View original content to download multimedia: SOURCE Nootropics Depot
Associated Press
23-05-2025
- Business
- Associated Press
U.S. Nootropics Market Trends Analysis and Growth Forecasts, 2025-2030 - Workplace and Academic Pressures Propel Consumer Shift Toward Cognitive Supplements
DUBLIN--(BUSINESS WIRE)--May 23, 2025-- The 'U.S. Nootropics Market Size, Share & Trends Analysis Report by Product (Natural, Synthetic), Form (Powder, Drinks, Gummies), Application, Distribution Channel, with Growth Forecasts, 2025-2030" report has been added to offering. The U.S. Nootropics Market was valued at USD 2.81 Billion in 2024, and is projected to reach USD 4.68 Billion by 2030, rising at a CAGR of 9.00% This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base. Natural products held a major share in 2024. This is due to consumer preferences for health and wellness solutions perceived as gentle and safe. This preference is strongly influenced by the association of 'natural' with fewer synthetic chemicals and potentially milder side effects. The effective marketing and branding of natural nootropics, capitalizing on the broader 'clean label' and plant-based trends, further propelled their market dominance by resonating strongly with health-conscious consumers seeking cognitive enhancement solutions aligned with natural and holistic wellness philosophies. The drinks segment held the largest share in 2024. This can be attributed to their inherent convenience and accessibility for consumers. Ready-to-drink nootropic beverages seamlessly integrate into daily routines, offering an easily consumable format compared to capsules or powders. Furthermore, drinks often provide a perception of faster absorption and quicker onset of effects, aligning with the immediate cognitive enhancement sought by many nootropic users. The beverage format also allows for greater flexibility in flavor profiles and taste masking, enhancing palatability and broadening appeal to a wider consumer base. Cognitive enhance held the largest share in the U.S. nootropics industry in 2024. The growth addresses the core and most widely recognized application of these substances. The fundamental driver is the increasing societal emphasis on optimal mental performance in various aspects of life, from demanding professional careers to competitive academic pursuits. Individuals are actively seeking solutions to improve focus, memory, attention span, and learning capabilities to gain a competitive edge and enhance productivity. Major market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others to gain more share of the market. U.S. Nootropics Market Report Highlights Why Should You Buy This Report? Companies Featured Key Attributes: Key Topics Covered: Chapter 1. Methodology and Scope Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Product Outlook 2.3. Form Outlook 2.4. Application Outlook 2.5. Distribution Channel Outlook Chapter 3. U.S. Nootropics Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.2. Industry Value Chain Analysis 3.2.1. Raw Material Outlook 3.2.2. Manufacturing & Technology Outlook 3.2.3. Profit Margin Analysis 3.3. Market Dynamics 3.3.1. Market Driver Analysis 3.3.2. Market Restraint Analysis 3.3.3. Market Opportunities 3.3.4. Market Challenges 3.4. Industry Analysis - Porter's Five Forces Analysis 3.5. Market Entry Strategies Chapter 4. U.S. Nootropics Market: Product Estimates & Trend Analysis 4.1. U.S. Nootropics Market, by Product: Key Takeaways 4.2. Product Movement Analysis & Market Share, 2024 & 2030 4.3. Market Estimates & Forecasts, by Product, 2018-2030 (USD Million) 4.3.1. Natural 4.3.1.1. Market estimates and forecast, 2018-2030 (USD Million) 4.3.2. Synthetic 4.3.2.1. Market estimates and forecast, 2018-2030 (USD Million) Chapter 5. U.S. Nootropics Market: Form Estimates & Trend Analysis 5.1. U.S. Nootropics Market, by Form: Key Takeaways 5.2. Form Movement Analysis & Market Share, 2024 & 2030 5.3. Market Estimates & Forecasts, by Form, 2018-2030 (USD Million) 5.3.1. Capsules/Tablets 5.3.2. Powder 5.3.3. Drinks 5.3.4. Gummies 5.3.5. Others (Liquid, patches, and novel delivery methods) Chapter 6. U.S. Nootropics Market: Application Estimates & Trend Analysis 6.1. U.S. Nootropics Market, by Application: Key Takeaways 6.2. Application Movement Analysis & Market Share, 2024 & 2030 6.3. Market Estimates & Forecasts, by Application, 2018-2030 (USD Million) 6.3.1. Cognitive Enhance 6.3.2. Mood & Stress Management 6.3.3. Sleep Optimization 6.3.4. Energy & Physical Performance 6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting) Chapter 7. U.S. Nootropics Market: Distribution Channel Estimates & Trend Analysis 7.1. U.S. Nootropics Market, by Distribution Channel: Key Takeaways 7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030 7.3. Market Estimates & Forecasts, by Form, 2018-2030 (USD Million) 7.3.1. Offline 7.3.2. Online Chapter 8. Competitive Analysis 8.1. Recent developments & impact analysis, by key market participants 8.2. Company Categorization 8.3. Participant's Overview 8.4. Financial Performance 8.5. Product Benchmarking 8.6. Company Market Share Analysis, 2024 (%) 8.7. Company Heat Map Analysis 8.8. Strategy Mapping 8.9. Company Profiles 8.9.1. Company Overview 8.9.2. Financial Performance 8.9.3. Product Portfolios 8.9.4. Strategic Initiatives For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: FITNESS & NUTRITION HEALTH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 05/23/2025 09:26 AM/DISC: 05/23/2025 09:25 AM
